CONFIRMED INVITED SPEAKERS
Dr Gay Crooks, University of California Los Angeles
Dr Jarrod Dudakov, Fred Hutchinson Cancer Research Center
Dr Daniel Gray, The Walter and Eliza Hall Institute
Dr Andras Nagy, Lunenfeld-Tanenbaum Research Institute
Prof Miles Prince, Peter MacCallum Cancer Centre
Prof Juan Carlos (JC) Zúñiga-Pflücker, University of Toronto
Prof Helen Heslop, Baylor College of Medicine
Prof Deborah White, SAHMRI
PROGRAM IS UNDER CONSTRUCTION - WATCH THIS SPACE
Book your travel early! The conference will commence on Wednesday 25th at 8am and conclude on Friday 27th at 5pm.
The conference will include an informal networking reception and poster session on Wednesday night as well as FREE PUBLIC FORUM & Final Summit!
The 2018 inaugural conference was an outstanding success, ~250 attended, 90% said they would come again. Since that time, many pre-clinical and clinical advances have been made. This new conference, with its stellar collection of international and national speakers will bring all these advances together
Why should you attend?
Immunotherapy to treat cancers is advancing at an astonishing pace and revolutionising the field
This international conference will define the state of current and next frontiers in immunotherapy research and clinical translation
It will combine and inform researchers, clinicians, industry, Government, patients, their carers and the general public. The excitement in this field is palpable.
Key topics will include:
CAR-T, CAR-NK, NKT, MAIT cells, anti-virus cytotoxic T cells,
Autologous versus allogeneic/off-the-shelf cell therapies,
Managing cytokine storm,
Immune check-point inhibitors,
Cancer vaccines and cancer antigen discovery,
Immune reconstitution and role of stem cells (HSC, iPSC).
Overcoming the tumour microenvironment and challenges inherent to solid cancers.
20 oral slots available for abstract submissions
Latest, ground breaking research.
Immunotherapy treatments and trials – now, near and not too far.
Free Public Forum – patient/clinician/expert panel: “all you want to know about immunotherapy but too afraid to ask…’
Final Summit “if money was not a problem”: future hopes, hurdles, solutions.